PSE reporting threshold erased
This article was originally published in The Tan Sheet
Executive Summary
The distribution of all amounts of pseudoephedrine and phenylpropanolamine fall under the Drug Enforcement Administration's enforcement, according to a final rule published July 7 in the Federal Register. The rule, which takes effect Aug. 6, is the latest step in DEA's implementation of the Combat Methamphetamine Epidemic Act. It eliminates the current threshold of 2.2 pounds to trigger DEA's reporting and recordkeeping requirements, according to a July 7 Federal Register notice. DEA says the unregulated distribution of any amount of PSE increases the likelihood the substance could be diverted to use for illicit meth manufacturing. DEA also imposed retail sales limits and tracking requirements under provisions of Combat Meth (1"The Tan Sheet" Nov. 26, 2007)
You may also be interested in...
Distributions Of All Amounts Of PSE Would Be Regulated Under DEA Rule
The Drug Enforcement Administration continues developing enforcement tools to implement the Combat Meth Act with a Nov. 20 notice of proposed rulemaking to regulate the distribution of all amounts of pseudoephedrine and phenylpropanolamine
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.